Barclays Has Lowered Expectations for Agilent Technologies (NYSE:A) Stock Price

Clinical OMICsHormone Cell Atlas Maps Body’s Chemical Messengers

Clinical OMICsSHIMMER: Routine Clinical Data Processed Into Scalable Disease State Markers

Endpoints NewsLilly obesity meds Foundayo and Zepbound to gain CVS coverage

Eli LillyEli Lilly Stock Heads for Record Close. CVS Weight-Loss Drug Coverage Drives It Higher. - Barron's

IlluminaIllumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research - PR Newswire

Thermo FisherThermo Fisher Launches E-Gel Power Snap Lite System - Contract Pharma

BioPharma DiveGSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’

BioWorldBreakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections

BioWorldTROP2 ADCs progress into first-line for lung, breast cancers

BioWorldLongbio to raise HK$1.4B in Hong Kong IPO for immunology work

Endpoints NewsFor wearables, it’s a GLP-1 world

Eli LillyCVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo - Fierce Pharma